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Gastric cancer is t�e second most common type 
of cancer worldwide and t�e leading cause of cancer-
related deat� in t�e world [�]. Gastric adenocarcinoma 
comprises 95% of t�e total number of gastric malig-
nancies� wit� a frequency t�at varies greatly among 
various geograp�ic locations [��4]. Studies �ave iden-
tified certain risk factors associated wit� t�is cancer. 
Helicobacter pylori is an official carcinogen t�at �as 
been found in most antral gastric cancers and results 
in increased risk of carcinogenesis of t�e stomac� and 
t�e infection of H. pylori leads to acid reduction and 
bacterial overgrowt� [5��]. �n addition� genetic analy-
sis �as revealed t�at activation of oncogenes and inac-
tivation of tumor suppressor genes are bot� involved 
in �uman gastric carcinogenesis [����]. However� t�e 
etiology of gastric cancer remains unclear. Recently� 
a number of reports �ave indicated t�at decreased 
gastric acid output is often observed in patients wit� 
gastric cancer and t�at a range of bacterial species 
can be cultured from gastric juice if t�e intragastric 
pH rises above 4.� [�����].
Ac�lor�ydria is defined as a failure of t�e intra-
gastric pH to fall to less t�an 4.� under maximal 
stimulation. �n several conditions� including pernicious 
anemia� autoimmune t�yroid disease� H. pylori infec-
tion� long-term treatment wit� proton pump in�ibitors� 
and mucolipidosis type �V� subnormal acid production 
is considered to contribute to ac�lor�ydria [�4���]. 
However� to date� studies describing t�e molecular 
mec�anism of ac�lor�ydria are lacking� especially 
explanations for w�y gastric cancer patients manifest 
ac�lor�ydria. T�us� questions regarding t�e cause 
and effect relations�ip between ac�lor�ydria and 
gastric cancer remain unanswered and require furt�er 
investigation. 
Gastric acid is produced by parietal cells in t�e 
stomac�� w�ic� contain an extensive secretory net-
work t�roug� w�ic� gastric acid is secreted into t�e 
lumen of t�e stomac�� w�ic� stays at  t�e low pH 
��.���.�� t�at is c�aracteristic of normal gastric acid. 
Gastric acid is an indispensable factor in t�e digestion 
of proteins� absorption of nutrients� and prevention of 
infection by bacteria-laden foods �many bacteria can-
not survive in suc� an acidic environment�. Regulation 
of gastric acid secretion is complex and involves a mul-
titude of factors affecting t�e integrity of t�e parietal 
cell. T�e �ormone gastrin and t�e paracrine agents 
�istamine and somatostatin� regulate gastric secretion 
[��]. Several additional intracellular events influence 
acid secretion from parietal cells suc� as elevation 
of intracellular calcium and cA�P and translocation 
of H+-K+-ATPase from cytoplasmic tubulovesicles to 
t�e apical plasma membrane [�� �9]. Recent stud-
ies in genetically engineered mouse models s�ow 
t�at gastric acid secretion requires �ig� levels of 
Cl-/HCO�
- exc�ange and one c�loride exc�anger is 
t�e anion exc�anger � �AE�� protein [��� ��].  T�e AE� 
protein is usually considered to be localized in baso-
lateral membrane of t�e parietal cell and to mediate 
Cl-/HCO�
- exc�ange� w�ic� is an essential element of 
t�e secretion process. AE�-/- mice �ave an ac�lor�y-
dric p�enotype and more alkaline gastric secretions 
[��� ��]. AE� generates H+ for secretion and extrudes 
intracellular HCO�
- across t�e basolateral membrane. 
T�us� cells support Cl- secretion t�roug� t�e apical 
membrane and via Cl- c�annels.
We previously reported an unexpected expression 
of AE� in �uman gastric cancer tissue and t�e alkaliza-
tion of t�e gastric cancer cell [�]. �n t�e present study� 
we raised polyclonal antibodies against an N-terminal 
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�� amino acid sequence of AE� in rat to identify and 
localize AE� protein in bot� cancerous and non-can-
cerous �uman gastric tissues. T�e result s�ow t�at 
t�e location of t�e AE� protein was restricted to t�e 
underside distribution of t�e fundus glands in bot� t�e 
stomac� fundus and t�e w�ole gastric body. �ntracel-
lular distribution of AE� was found on t�e nuclear mem-
brane. T�e AE� protein was clearly down-regulated in 
gastric body tumors.
MATERIALS AND METHODS
Patients. A total of �� paraffin-embedded gastric 
tumor specimens from patients wit� adenocarcinoma 
�based on clinical and pat�ologic diagnosis� and 
�6 non-cancer control patients wit� diagnosed gas-
tritis �Lis�ui �ospital� Z�ejiang� C�ina� were randomly 
selected for t�ese retrospective studies. Clinical in-
formation was available. T�e patients were primarily 
diagnosed wit� gastric cancer and none of t�em �ad 
received c�emot�erapy or radiation treatments before 
surgery. After analysis of AE� expression� t�e patients 
were followed for ���� mont�s.T�e experiment is per-
missioned by t�e Et�ic Committee of S�ang�ai Jiao 
Tong University and t�e patients were informed.
Immunohistochemistry. Gastric tissue speci-
mens were obtained by needle biopsy or during gastric 
surgery. Processing of samples and immunostaining 
were described in our previous paper [�]. Briefly� par-
affin-embedded �uman gastric specimens were fixed 
wit� 4% paraformalde�yde �pH �.4�. Tissue sections 
were cut at � µm t�ickness on a rotary microtome 
�Leica� and dewaxed in xylene and re�ydrated using 
95% et�anol. To reveal antigens� sections were placed 
in citrate buffer and �eated in a microwave oven for 
�� min. After t�at� �� min incubations in �% H�O� 
were done to block endogenous peroxidase activity. 
Nonspecific binding was prevented by incubating 
sections in 5% BSA for �� min. Sections were incu-
bated overnig�t at 4 °C wit� anti-AE� antibodies� and 
diluted � : ��� in �� m� PBS �pH �.4�. AE� polyclonal 
antibodies �Alp�a Diagnostic� USA� are against rat 
AE� N-terminal �� amino acids. T�e sequence is �5% 
conserved in �umans and t�e antibody �as been used 
in our previous researc� [�4].  For lig�t microscopy� 
sections were incubated wit� HRP-linked goat anti-
rabbit secondary antibodies ��aixin� C�ina�� visuali-
zed by t�e DAB tec�nique� and counterstained using 
�ayer’s �ematoxylin.
Immunofluorescent staining. T�e paraffin-em-
bedded tissue sections from gastric cancer or non 
cancer patients were cut and t�en deparaffinized and 
re�ydrated in a graded series of et�anol. Sections were 
placed in citrate buffer and �eated in a microwave oven 
for �� min followed by 5% BSA for �� min for prevent-
ing non-specific binding. Slides were stained overnig�t 
at 4 °C wit� anti-rat polyclonal AE� antibodies �Alp�a 
Diagnostic� USA�. T�en t�ey were incubated wit� 
secondary goat anti-rabbit antibodies �Santa Cruz� 
USA� linked wit� F�TC and analyzed by fluorescence 
microscopy �Leica� Germany�.
Pathology grade and score. �mmunoreactivity in 
gastric tissues was graded from � to � according to bot� 
t�e intensity and t�e distribution of t�e staining. T�e final 
score for eac� sample was obtained by adding toget�er 
t�e intensity score �� to �: �� negative staining; �� weakly 
staining; �� moderate staining; �� intense staining� and 
t�e distribution score �� to 4: for < ��%� ��%��5%� 
�6%�5�%� 5�%��5%� or > �5% staining� respectively�. 
All cancer patients were classified as grade ����� �total 
stage ���V� according to TN� classification. 
Statistical analyses. T�e association of AE� ex-
pression wit� cancerous and non-cancerous tissues 
from gastric fundus� body and antrum was evaluated 
by �ann-W�itney U test. An immunoreactivity score 
was obtained from an average of summation calcu-
lated by adding toget�er all final scores. T�e formula 
used was score = mean ± SE�.
RESULTS AND DISCUSSION
T�e AE family includes AE�� AE� and AE� and media-
tes t�e exc�ange of Cl- and HCO�
- across t�e plasma 
membrane. �t is involved in t�e regulation of cellular pH� 
cell volume and cellular metabolism. AE� is expressed 
in eryt�rocytes and in gastric adenocarcinoma. AE� is 
ubiquitously expressed in tissues and AE� is found in 
brain� retina and �eart. 
Studies of mRNA levels s�ow t�at AE� is most 
abundantly expressed in stomac� and is apparently 
located in t�e basolateral plasma membrane [�5� �6]. 
However� t�e contradictory results for t�e AE� protein 
�ave been reported in c�oroid plexus epit�elial cells 
[��]. Using immuno�istoc�emistry� we �ave found 
positive AE� immunostaining in �uman normal gastric 
specimens� distributed across t�e underside of gastric 
fundus glands and body. However� AE� immunostain-
ing in t�e gastric body was more dense and centralized 
t�an in t�e fundus. �n contrast� positive staining is rarely 
found in t�e antrum �Fig. �� a� c� e�. To furt�er confirm 
t�e distribution of AE�� immunofluorescent staining 
was done on t�e same �uman gastric specimens. As 
s�own on Fig. �� b� d� f� AE� was expressed in cells t�at 
were mainly located in t�e glandular area of t�e gastric 
fundus and t�e body� and is t�erefore consistent wit� 
immuno�istoc�emical data. T�e staining distribution 
mostly overlapped wit� parietal cells� suggesting 
parietal cell-related expression of AE� protein. All �6 
non-cancer specimens t�at were analyzed �ad posi-
tive staining in bot� gastric fundus and gastric body. 
�n addition� t�e protein was mainly localized at t�e 
nuclear membrane in gastric body �Fig. �� d�. However� 
t�e same profile was not found in t�e gastric fundus 
�Fig. �� a�. T�is differs from t�e plasma membrane 
location of AE� in ot�er epit�elial cells. Previous re-
ports �ave demonstrated t�at different variants of AE� 
protein were located in t�e different regions in different 
tissues. For example� AE�a was located in t�e apical 
plasma membrane in biliary and intestinal epit�elial 
cells w�ereas ot�er AE� variants �ave been s�own to 
be localized in Golgi apparatus and mitoc�ondria. All 
t�ese data suggest t�at one or more AE� variants may 
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Fig. 1. �mmunostaining of AE� protein expression in normal gastric mucosa. Left panel: immuno�istoc�emical staining; Rig�t panel: 
immunofluorescence staining; a and b� gastric fundus; c and d� gastric body; e and f� gastric antrum. Original magnification ×��
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take part in t�e regulation of secretion of gastric acid 
in t�e parietal cells. �n addition� it is interesting t�at in 
two from six noncancerous antrum specimens �ave 
s�own positive staining for AE� protein. 
Next� we initiated an investigation of AE� expression 
in �uman gastric tumor samples and compared t�at 
data wit� nontransformed tissue �Table�. �n �� �uman 
gastric cancer tissue specimens� immuno�istoc�emi-
cal staining of AE� was significantly decreased in tu-
mors of gastric body. �n contrast� tumors of antrum only 
weakly expressed AE� protein. Fig. � s�ows a typical 
immuno�istoc�emical staining of tumor tissues from 
gastric fundus �a� × ����� body �b� × ���� and antrum 
�c� × ����. T�e differential expression of AE� protein in 
fundus� body and antrum of bot� non-cancerous and 
cancerous tissues was statistically analyzed by com-
paring protein immunoreactivity scores �Fig. 4�. T�e 
finding of decreased AE� immunoreactivity in cancer-
ous gastric body tissue suggests t�at t�e expression 
of t�e AE� protein expression is lower in gastric cancer 
patients. �t was assumed t�at suc� reduction in AE� 
expression resulted from loss of parietal cells because 
of t�e intestinal metaplasia of gastric glands. However� 
t�e decreased expression of AE� was observed in all 
t�e subtypes of gastric cancer specimens studied by 
us. �oreover� t�e AE� protein was also expressed 
in normal intestinal mucosa. On t�e ot�er �and� t�e 
loss of parietal cells did not occur in all gastric cancer 
specimens� w�ereas decreased expression of AE� was 
found in all types of gastric body cancer investigated 
in our experiment including normal tissue adjacent to 
tumor. AE� expression was not robustly correlated wit� 
gastric cancer. Gastric acid secretion by parietal cells 
is regulated bot� centrally and perip�erally. Until re-
cently� t�ere �ad not been strong evidence t�at t�e AE� 
protein �as an essential role in gastric acid secretion. 
Analysis of gastric secretions after stimulation by �ista-
mine s�ows t�at AE�-/- mice develop ac�lor�ydria and 
t�at t�eir gastric secretions are more alkaline. T�ese 
findings are supported by data from ot�er experiments 
[��� ��]� t�us� reinforcing our conclusion t�at AE� �as 
a central role in t�e regulation of acid secretion. Low 
Table. Histopathological and clinicopathological data from studies of patients with gastric cancer and of controls. 
Patient Disease
Type of Tumor Tumor Tumor Follow-up
Location AE2 Immunoreactivity ScoreBiopsy Size (cm) Stage Grade Statistics (mo)No. Age(y)/Sex Intensity Range Final Score
1 67/M N EB Fundus 1 3 4
2 50/M N EB Fundus 2 4 6
3 56/F N EB Fundus 2 4 6
4 34/F N EB Fundus 2 3 5
5 37/F N EB Fundus 2 3 5
6 47/F N EB Body 3 4 7
7 45/M N EB Body 2 4 6
8 46/M N EB Body 3 4 7
9 49/M N EB Body 3 4 7
10 46/M N EB Body 2 4 6
11 55/F N EB Antrum 0 0 0
12 43/M N EB Antrum 0 0 0
13 26/M N NB Antrum 2 0 2
14 43/M N NB Antrum 0 0 0
15 29/M N EB Antrum 2 0 2
16 53/F N EB Antrum 0 0 0
17 71/M GC SB 5.0*5.0 III III 11 Fundus 1 3 4
18 51/M GC SB 10.0*8.0 III III died Fundus 0 0 0
19 74/M GC SB 2.5*2.5 I II–III 10 Body 0 0 0
20 46/M GC SB 5.0*4.5 IV III 12 Body 0 0 0
21 51/M GC SB 5.0*10.0 III III 12 Body 0 0 0
22 74/F GC SB 4.0*4.0 I I–II 10 Body 0 0 0
23 55/M GC SB 2.0*1.0 II III 11 Body 1 1 2
24 36/F GC SB 2.5*2.0 I III 13 Body 0** 0 0
25 75/M GC SB 10.0*7.0 II III 13 Body 0 0 0
26 54/F GC SB 2.0*2.0 I III 12 Body 0 0 0
27 70/M GC SB 7.0*5.0 IV II–III died Body 0 0 0
28 48/M GC SB 5.5*7.0 III II 13 Body 0 0 0
29 62/M GC SB 3.0*5.0 I II–III 10 Body 0 0 0
30 73/M GC SB 1.0*0.5 IV II–III 13 Body 0 0 0
31 77/M GC SB 2.0*1.5 I I 11 Body 0 0 0
32 79/M GC SB 10.0*8.0 IV II 3 Body 0 0 0
33 60/M GC SB 8.0*5.0 III III 12 Antrum 1 1 2
34 37/M GC SB 3.0*3.0 II II–III 10 Antrum 1 4 5
35 71/M GC SB 3.0*4.0 I II 13 Antrum 1 0 1
36 54/F GC SB 5.0*7.0 IV III died Antrum 1 4 5
37 73/M GC SB 4.0*2.0 II II–III 10 Antrum 1 3 4
38 55/M GC SB 2.0*1.0 II III 11 Antrum 1 3 4
39 70/M GC SB 3.0*5.0 I II–III 10 Antrum 1 3 4
40 81/M GC SB 2.2*2.0 III III 13 Antrum 1 4 5
41 76/M GC SB 2.0*2.0 III II 12 Antrum 1 1 2
42 60/M GC SB 8.5*5.0 III III 12 Antrum 1 1 2
43 87/M GC SB 5.0*4.0 II II 12 Antrum 1 0 1
44 65/M GC SB 1.0*1.0 II II–III 10 Antrum 1 3 4
45 57/M GC SB 4.0*4.0 III II–III 11 Antrum 1 0 1
46 37/M GC SB 3.0*3.0 II II–III 10 Antrum 1 4 5
47 55/F GC SB 4.0*4.0 III II–III 10 Antrum 1 0 1
48 69/M GC SB 4.0*4.0 III II 10 Antrum 1 4 5
49 61/M GC SB   4.0*4.0 III III 11 Antrum 1 3 4
Notes: ** Evaluation was not feasible because of background; EB — endoscopic biopsy; SB – surgical biopsy; NB – needle biopsy; GC – gastric cancer; 
mo — month.
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Fig. 2. �mmuno�istoc�emical staining of AE� expression in cells of �uman normal gastric fundus �a, b�� body �c, d� and antrum 
�e, f�. For easier viewing of t�e staining� t�e structures indicated by an arrow were magnified �left� × ��� rig�t� × ���� 
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expression and functional insufficiency of AE� in t�e 
stomac� results in low acid secretion� w�ic� can lead 
to gastritis and adenocarcinoma. 
Our findings raise a question about w�et�er t�e 
manifestation of ac�lor�ydria in gastric cancers results 
from t�e loss of parietal cells or atrop�y and impaired 
viability of parietal cells in t�e stomac�. Several fin-
dings based on t�e AE�-/- animal model suggest t�at 
loss of AE� does not �ave a major effect on parietal cell 
viability and indicate t�at any reduction in t�e number 
of parietal cells was not excessive and not sufficient 
to account for t�e ac�lor�ydria p�enotype. Decreased 
expression of AE� reduced t�e overall secretory ca-
pacity of t�e parietal cells� w�ic� are important for 
maintaining a balance between apical and basolateral 
transport mec�anisms t�at lead to ac�lor�ydria. Our 
results indicate t�at decreased expression of AE� may 
involve a failure of pH �omeostasis during acid secre-
tion in gastric cancer cells. T�e full significance of 
AE� expression for understanding and treating gastric 
cancer will require furt�er study.
Fig. 4. �mmunoreactivity scores for AE� expression in gastric 
tissues. a: normal gastric tissue; b: gastric tumor. �n eac� group� 
t�e score is expressed as mean ± SD
*P < �.��� is for comparisons wit� t�e gastric antrum group; 
**P < �.��� is for comparisons wit� t�e non-cancerous gastric 
body group; ***P < �.�5 is for comparisons wit� t�e non-cancer-
ous gastric antrum group.
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ЭКСПРЕССИЯ АНИОННОГО ОБМЕННИКА 2 В ОПУХОЛЕВОЙ 
ТКАНИ ЖЕЛУДКА
Анионный обменник 2 (АЕ2), который опосредует перенос Cl-/HCO3
- через плазматическую мембрану, экспрессируется 
клетками разных тканей. Самый высокий уровень экспрессии АЕ2 в желудке, поскольку этот белок отвечает за поглощение 
ионов Cl-, которые впоследствии используются для секреции HCl. Цель: Изучить изменения в экспрессии АЕ2 при раке 
желудка. Методы: исследована экспрессия АЕ2 в нормальных тканях (n = 16) и опухолях желудка (n = 33) с применением 
методов иммуногистохимии и иммунофлуоресценции. Результаты: в нетрансформированной ткани желудка в фундальной 
железе выявляли сильную положительную реакцию, что свидетельствует об экспрессии АЕ2 париетальными клетками, 
причем экспрессия АЕ2 была локализирована в ядерной мембране и в ядре. В опухолях желудка (фундального отдела (n = 
2), тела (n = 14) и антрального отдела (n = 17)), отобранных случайным образом, был проведен анализ экспрессии АЕ2. 
Иммуногистохимическое исследование показало снижение экспрессии АЕ2 во всех 14 случаях рака тела желудка. Окра-
шивание АЕ2 в образцах рака антрального отдела желудка было менее интенсивным и диффузным. Выводы: полученные 
данные позволяют предположить наличие связи между экспрессией АЕ2 и развитием рака желудка, а также ахлоргидрией, 
отмечаемой у больных раком желудка.
Ключевые слова: анионный обменник 2, иммуногистохимия, ахлоргидрия, рак желудка, канцерогенез, кислота желудоч-
ного сока.
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